Open, multi-center randomized research and clinical program MINOTAUROS: intermediate data analysis
Aim. To assess indapamide (Arifon retard) effects on blood pressure (BP), carbohydrate, lipid, purine and electrolyte metabolism in patients with mild arterial hypertension (AH) and metabolic syndrome (MS). Material and methods. In total, 573 patients with mild AH and MS participated in MINOTAUROS S...
Main Authors: | I. E. Chazova, V. B. Mychka |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«SILICEA-POLIGRAF» LLC
2006-04-01
|
Series: | Кардиоваскулярная терапия и профилактика |
Subjects: | |
Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1162 |
Similar Items
-
Diuretics in patients with metabolic disturbances
by: I. E. Chazova, et al.
Published: (2007-04-01) -
Use of diuretics in hypertensive patients with metabolic disturbances
by: Yuliya Valer'evna Zhernakova, et al.
Published: (2013-06-01) -
Menopausal metabolic syndrome after hysterectomy
by: V. I. Podzolkov, et al.
Published: (2005-12-01) -
ANTIHYPERTENSIVE EFFICACY OF VERAPAMIL PLUS INDAPAMIDE IN PATIENTS WITH METABOLIC SYNDROME
by: E. M. Idrisova, et al.
Published: (2016-01-01) -
Long-term indapamide retard therapy in adolescents with Stage I arterial hypertension
by: I. V. Logacheva, et al.
Published: (2011-04-01)